论文信息 - Mucocutaneous Ulcerations and Pancytopenia due to Methotrexate Overdose

Mucocutaneous Ulcerations and Pancytopenia due to Methotrexate Overdose

Methotrexate (MTX) is an antifolic drug used in the treatment of immune-mediated and neoplastic diseases. Initiation or dosage changes in MTX therapy can cause mucositis and bone marrow suppression. Skin lesions due to acute MTX toxicity are rare, but they serve as a herald for later-onset pancytopenia. Therefore, identification of those cutaneous lesions might help to initiate rescue strategies at an early stage. Here we describe a case with mucocutaneous ulcerations and pancytopenia due to overdosed MTX.

[1] L. French,et al. Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris , 2016, Dermatology.

[2] D. Umrigar,et al. Acute Methotrexate Toxicity: A Fatal Condition in Two Cases of Psoriasis , 2014, Case reports in dermatological medicine.

[3] Kelly B. Conner,et al. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity. , 2014, Dermatology online journal.

[4] S. Dogra,et al. Systemic methotrexate therapy for psoriasis: past, present and future , 2013, Clinical and experimental dermatology.

[5] Y. Tay,et al. A case of acute methotrexate toxicity. , 2011, Annals of the Academy of Medicine, Singapore.

[6] P. Jaen,et al. Focal skin toxicity related to methotrexate sparing psoriatic plaques. , 2010, Dermatology online journal.

[7] N. Scheinfeld. Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions. , 2006, Dermatology online journal.

[8] M. Heenen,et al. Methotrexate induces apoptotic cell death in human keratinocytes , 1998, Archives of Dermatological Research.

[9] C. Lawrence,et al. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. , 1984, Journal of the American Academy of Dermatology.